Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients

Bortezomib induced peripheral neuropathy is a dose-limiting side effect and a major concern in the treatment of multiple myeloma. To identify genetic risk factors associated with the development of this side effect in bortezomib treated multiple myeloma patients, a pharmacogenetic association study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Corthals, Sophie L., Kuiper, Rowan, Johnson, David C., Sonneveld, Pieter, Hajek, Roman, van der Holt, Bronno, Magrangeas, Florence, Goldschmidt, Hartmut, Morgan, Gareth J., Avet-Loiseau, Hervé
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2011
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208695/
https://ncbi.nlm.nih.gov/pubmed/21791469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.041434
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars